Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Passive antibody protection of cats against feline immunodeficiency virus infection.

Literature DB >> 8383246

Passive antibody protection of cats against feline immunodeficiency virus infection.

T Hohdatsu¹, R Pu, B A Torres, S Trujillo, M B Gardner, J K Yamamoto.

Abstract

All six cats passively immunized with sera from either feline immunodeficiency virus (FIV)-vaccinated cats or cats infected with FIV (Petaluma strain) were protected from homologous FIV infection at a challenge dose that infected all six control cats. Passive immunization with sera from cats vaccinated with uninfected allogeneic T cells used to grow the vaccine virus did not protect either of two cats against the same FIV challenge. These results suggest that antiviral humoral immunity, perhaps in synergy with anticellular antibodies, may be responsible for previously reported vaccine protection.

Entities: Disease Species

Mesh：

Substances：

Year: 1993 PMID： 8383246 PMCID： PMC240393

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

19 in total

1. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom.

Authors: M J Hosie; C Robertson; O Jarrett
Journal: Vet Rec Date: 1989-09-09 Impact factor: 2.695

2. Feline immunodeficiency virus: A commentary.

Authors: R C Povey; G J Hawkins
Journal: Can Vet J Date: 1989-07 Impact factor: 1.008

3. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma.

Authors: D Vittecoq; B Mattlinger; F Barre-Sinoussi; A M Courouce; C Rouzioux; C Doinel; M Bary; J P Viard; J F Bach; P Rouger
Journal: J Infect Dis Date: 1992-02 Impact factor: 5.226

4. Anti-cell antibody in macaques.

Authors: E J Stott
Journal: Nature Date: 1991-10-03 Impact factor: 49.962

5. AIDS vaccine developments.

Authors: M P Cranage; L A Ashworth; P J Greenaway; M Murphey-Corb; R C Desrosiers
Journal: Nature Date: 1992-02-20 Impact factor: 49.962

Review 6. Feline immunodeficiency virus as a model for AIDS vaccination.

Authors: O Jarrett; J K Yamamoto; J C Neil
Journal: AIDS Date: 1990 Impact factor: 4.177

7. Replication of cat leukemia virus in cell suspension cultures.

Authors: G H Theilen; T G Kawakami; J D Rush; R J Munn
Journal: Nature Date: 1969-05-10 Impact factor: 49.962

8. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.

Authors: P Putkonen; R Thorstensson; L Ghavamzadeh; J Albert; K Hild; G Biberfeld; E Norrby
Journal: Nature Date: 1991-08-01 Impact factor: 49.962

9. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines.

Authors: J K Yamamoto; C D Ackley; H Zochlinski; H Louie; E Pembroke; M Torten; H Hansen; R Munn; T Okuda
Journal: Intervirology Date: 1991 Impact factor: 1.763

10. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

Authors: E A Emini; W A Schleif; J H Nunberg; A J Conley; Y Eda; S Tokiyoshi; S D Putney; S Matsushita; K E Cobb; C M Jett
Journal: Nature Date: 1992-02-20 Impact factor: 49.962

15 in total

1. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.

Authors: M J Hosie; T Dunsford; D Klein; B J Willett; C Cannon; R Osborne; J Macdonald; N Spibey; N Mackay; O Jarrett; J C Neil
Journal: J Virol Date: 2000-10 Impact factor: 5.103

Review 2. Advances in FIV vaccine technology.

Authors: Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal: Vet Immunol Immunopathol Date: 2008-01-20 Impact factor: 2.046

3. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.

Authors: James K Coleman; Ruiyu Pu; Marcus M Martin; Ezra N Noon-Song; Raphael Zwijnenberg; Janet K Yamamoto
Journal: Vaccine Date: 2013-06-22 Impact factor: 3.641

4. Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.

Authors: M J Hosie; J N Flynn
Journal: J Virol Date: 1996-11 Impact factor: 5.103

5. Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Authors: J R Mascola; M G Lewis; G Stiegler; D Harris; T C VanCott; D Hayes; M K Louder; C R Brown; C V Sapan; S S Frankel; Y Lu; M L Robb; H Katinger; D L Birx
Journal: J Virol Date: 1999-05 Impact factor: 5.103

6. Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors: K J Hasenkrug; D M Brooks; B Chesebro
Journal: Proc Natl Acad Sci U S A Date: 1995-11-07 Impact factor: 11.205

Review 7. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors: M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal: Clin Microbiol Rev Date: 1995-01 Impact factor: 26.132

Review 8. Lentivirus-induced immune dysregulation.

Authors: Mary B Tompkins; Wayne A Tompkins
Journal: Vet Immunol Immunopathol Date: 2008-01-19 Impact factor: 2.046

9. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Authors: F Baldinotti; D Matteucci; P Mazzetti; C Giannelli; P Bandecchi; F Tozzini; M Bendinelli
Journal: J Virol Date: 1994-07 Impact factor: 5.103

10. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors: P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal: J Virol Date: 1999-01 Impact factor: 5.103